Stella Pharma Corporation (TYO:4888)
Japan
· Delayed Price · Currency is JPY 317.00
+6.00 (1.93%)
Apr 25, 2025, 3:30 PM JST
Stella Pharma Revenue
Stella Pharma had revenue of 85.00M JPY in the quarter ending December 31, 2024, with 80.85% growth. This brings the company's revenue in the last twelve months to 323.00M, up 27.17% year-over-year. In the fiscal year ending March 31, 2024, Stella Pharma had annual revenue of 269.00M with 17.47% growth.
Revenue (ttm)
323.00M
Revenue Growth
+27.17%
P/S Ratio
33.40
Revenue / Employee
7.34M
Employees
44
Market Cap
10.79B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Shionogi & | 456.87B |